3 research outputs found
Direct Quantification of Circulating MiRNAs in Different Stages of Nasopharyngeal Cancerous Serum Samples in Single Molecule Level with Total Internal Reflection Fluorescence Microscopy
MicroRNAs
(miRNAs) are small noncoding RNAs that regulate human
gene expression at the post-transcriptional level. Growing evidence
indicates that the expression profile of miRNAs is highly correlated
with the occurrence of human diseases including cancers. Playing important
roles in complex gene regulation processes, the aberrant expression
pattern of various miRNAs is implicated in different types and even
stages of cancer. Besides localizing in cells, many of these miRNAs
are found circulating around the body in a wide variety of fluids
such as urine, serum and saliva. Surprisingly, these extracellular
circulating miRNAs are highly stable and resistant to degradation,
and therefore, are considered as promising biomarkers for early cancer
diagnostic via noninvasive extraction from body fluids. Unfortunately,
the abundance of these small RNAs is ultralow in the body fluids,
making it challenging to quantify them in complex sample matrixes.
Establishing a sensitive, specific yet simple assay for an accurate
quantification of circulating miRNAs is therefore desirable. Our group
previously reported a sensitive and specific detection assay of miRNAs
in single molecule level with the aid of total internal reflection
fluorescence microscopy. In this work, we advanced the assay to differentiate
the expression of a nasopharyngeal carcinoma (NPC) up-regulator hsa-mir-205
(mir-205) in serum collected from patients of different stages of
NPC. To overcome the background matrix interference in serum, a locked
nucleic acid-modified molecular beacon (LNA/MB) was applied as the
detection probe to hybridize, capture and detect target mir-205 in
serum matrix with enhanced sensitivity and specificity. A detection
limit of 500 fM was achieved. The as-developed method was capable
of differentiating NPC stages by the level of mir-205 quantified in
serum with only 10 μL of serum and the whole assay can be completed
in 1 h. The experimental results agreed well with those previously
reported whereas the quantity of miR-205 determined by our assay was
found comparable to that of quantitative reverse transcription polymerase
chain reaction (qRT-PCR), supporting that this assay can be served
as a promising noninvasive detection tool for early NPC diagnosis,
monitoring and staging
Additional file 1: of Silica nanoparticles induce neurodegeneration-like changes in behavior, neuropathology, and affect synapse through MAPK activation
(Methods. Effects of FITC-SiO2-NPs on behavior in mice (Figure S1.) Effects of FITC-SiO2-NPs on phosphorylations of p38 and CREB and its effectors in total lysates of frontal cortex and hippocampus (Figure S2.) Protein levels of synaptophysin and synapsin I in the primary culture of cortical neurons exposed to NP for 48h as analyzed by Western blot (Figure S3.) DOCX 1064 kb
Effective Theranostic Cyanine for Imaging of Amyloid Species in Vivo and Cognitive Improvements in Mouse Model
We report herein an
investigation of carbazole-based cyanine,
(<i>E</i>)-4-(2-(9-(2-(2-methoxyethoxy)Âethyl)-9<i>H</i>-carbazol-3-yl)-vinyl)-1-methyl-quinolin-1-iumiodide (SLM), as an
effective theranostic agent for Alzheimer’s disease (AD). This
cyanine exhibited desirable multifunctional and biological properties,
including amyloid-β (Aβ)-oligomerization inhibition, blood–brain
barrier permeability, low neurotoxicity, neuroprotective effect against
Aβ-induced toxicities, high selectivity and strong binding interactions
with Aβ peptide/species, good biostability, as well as strong
fluorescence enhancement upon binding to Aβ species for diagnosis
and therapy of AD. This cyanine has been successfully applied to perform
near-infrared in vivo imaging of Aβ species in transgenic AD
mouse model. The triple transgenic AD mice intraperitoneally treated
with SLM showed significant recovery of cognitive deficits. Furthermore,
those SLM-treated mice exhibited a substantial decrease in both of
oligomeric Aβ contents and tau proteins in their brain, which
was attributed to the induction of autophagic flux. These findings
demonstrated for the first time that SLM is an effective theranostic
agent with in vivo efficacy for diagnosis and treatment of AD in mouse
models